orasure technologies inc
(OSUR:NASDAQ GS)
orasure technologies inc (OSUR) Snapshot
|
Open
$4.41
|
Previous Close
$4.39
|
|
|
Day High
$4.48
|
Day Low
$4.34
|
|
|
52 Week High
07/9/12 - $14.01
|
52 Week Low
04/26/13 - $4.24
|
|
|
Market Cap
241.6M
|
Average Volume 10 Days
317.7K
|
|
|
EPS TTM
$-0.40
|
Shares Outstanding
55.5M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
orasure technologies inc (OSUR) Related Businessweek News
No Related Businessweek News Foundorasure technologies inc (OSUR) Details
OraSure Technologies, Inc. develops, manufactures, and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies. Its diagnostic products include tests that are performed on a rapid basis at the point of care; and tests, which are processed in a laboratory. The principal products comprise OraQuick ADVANCE HIV-1/2, OraQuick In-Home HIV Test, OraQuick HCV, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene DISCOVER, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, Intercept, MICRO-PLATE DOA Assays, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, the company, through its subsidiary, DNA Genotek Inc., manufactures and sell kits used to collect, stabilize, and store samples of genetic material for molecular testing in the academic research, clinical genetic testing, pharmacogenomics, personalized medicine, and animal and livestock genetics markets. Its OraGene DNA sample collection kit provides an all-in-one system for the collection, stabilization, and transportation of DNA from human saliva. Further, the company offers medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Additionally, it sells certain immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and the FDA 510(k) cleared Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities in the United States and internationally. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
orasure technologies inc (OSUR) Top Compensated Officers
orasure technologies inc (OSUR) Key Developments
OraSure Technologies Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company's net loss was $10.2 million, or $0.18 per basic and diluted share, which compares to a net loss of $3.3 million, or $0.07 per basic and diluted share, for the first quarter of 2012. Net revenues were $21.2 million compared with $20.9 million a year ago. Operating loss was $10.6 million compared with $3.7 million a year ago. Loss before income taxes was $10.6 million compared with $3.8 million a year ago. Capital expenditures were $0.48 million compared with $0.31 million a year ago. Cash used in operating activities was $7.7 million compared with $1.4 million a year ago. The company expects consolidated net revenues to range from $23.5 to $24.0 million and is projecting a consolidated net loss of approximately $0.15 - $0.16 per share for the second quarter of 2013.
OraSure Technologies Inc. announced that they will report Q1, 2013 results at 4:00 PM, US Eastern Standard Time on May 08, 2013
OraSure Technologies Inc., Q1 2013 Earnings Call, May 08, 2013
| Recently Viewed | |||
| OSUR:US | $4.35 USD | -0.04 | |
| Company | Last | Change |
| Cornerstone Therapeutics Inc | $8.34 USD | -0.20 |
| Derma Sciences Inc | $13.76 USD | -0.06 |
| Nymox Pharmaceutical Corp | $5.19 USD | -0.07 |
| Psychemedics Corp | $11.47 USD | +0.14 |
| Sciclone Pharmaceuticals Inc | $4.77 USD | -0.10 |
| View Industry Companies | ||
Industry Analysis
OSUR
Industry Average
| Valuation | OSUR | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.8x |
|
| Price/Book | 1.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.9x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ORASURE TECHNOLOGIES INC, please visit www.orasure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








